Catalogo dei prodotti della ricerca

AMADORI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.481
EU - Europa 474
AS - Asia 387
SA - Sud America 12
AF - Africa 4
Totale 2.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.461
SG - Singapore 167
IT - Italia 156
IN - India 118
SE - Svezia 118
CN - Cina 98
FI - Finlandia 47
DE - Germania 41
UA - Ucraina 27
CA - Canada 18
BG - Bulgaria 16
RO - Romania 15
RU - Federazione Russa 13
AR - Argentina 11
BE - Belgio 10
IE - Irlanda 10
FR - Francia 8
GB - Regno Unito 7
TG - Togo 3
KR - Corea 2
LT - Lituania 2
MX - Messico 2
AT - Austria 1
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
HU - Ungheria 1
NL - Olanda 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.358
Salva come PNG Salva come JPEG
Città #
Fairfield 210
Chandler 123
Singapore 119
Princeton 89
Woodbridge 89
Ashburn 78
Seattle 73
Cambridge 69
Wilmington 69
Houston 65
Plano 51
Santa Clara 50
Beijing 49
Ann Arbor 42
Des Moines 33
Florence 31
Millbury 29
Bremen 23
Dearborn 22
Andover 17
Boston 16
Sofia 16
San Paolo di Civitate 15
Lawrence 14
San Diego 14
Norwalk 13
Federal 11
Brussels 10
Dublin 10
Rome 10
Toronto 10
Kunming 9
Moscow 7
Ottawa 7
Falls Church 6
Hefei 6
Jacksonville 6
San Mateo 6
Helsinki 5
Naples 5
Bühl 4
Trento 4
Bologna 3
Buffalo 3
Fuzhou 3
Lomé 3
Los Angeles 3
Shenyang 3
Bisceglie 2
Boardman 2
Cagliari 2
Castellarano 2
Chengdu 2
Falkenstein 2
Hyderabad 2
Jinan 2
Lecco 2
Milan 2
Nanchang 2
Nanjing 2
Napoli 2
New York 2
Redmond 2
Reggio Nell'emilia 2
Belpasso 1
Belvedere Marittimo 1
Berlin 1
Budapest 1
Calvisano 1
Capena 1
Catania 1
Clearwater 1
Cologna Veneta 1
Curinga 1
DeKalb 1
Edinburgh 1
Frankfurt am Main 1
Genova 1
Guangzhou 1
Hebei 1
Indiana 1
Istanbul 1
Malfa 1
Mannheim 1
Massa Fiscaglia 1
Medicina 1
Montreal 1
Muizenberg 1
Nanning 1
Noisy-le-sec 1
Nutley 1
Padova 1
Palermo 1
Piombino 1
Pomezia 1
Rho 1
Riva 1
San Pablo 1
Santiago 1
Shanghai 1
Totale 1.621
Salva come PNG Salva come JPEG
Nome #
Prevenzione e terapia della meningosi leucemica 141
Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: An individual patient data meta-analysis 86
Randomized Phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: Health-related quality-of-life outcomes 78
BLOOD COAGULATION ABNORMALITIES IN CHRONIC MYELOID LEUKAEMIA. 75
High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC-GIMEMA AML-12 trial 71
High serum IL-2 levels are predictive of prolonged survival in multiple myeloma 64
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): Phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial) 61
The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia 58
null 55
null 55
Myelodysplastic syndromes in childhood: Description of seven cases 54
null 52
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study 51
null 51
null 51
Therapy of childhood Acute Myelogenous Leukemia: an update of the AIEOP/LAM 8204 Study 51
DHAP treatment: results of 18 patients with refractory or recurrent non Hodgkin's lymphoma. 51
Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia. 45
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia 45
Intensified early therapy for childhood acute myeloid leukemia: pilot studies for the AIEOP cooperative group 45
Childhood myelodysplastic syndrome (MDS): report of 4 cases 44
I linfomi non-Hodgkin 43
null 43
null 43
null 40
CT brain scan findings in children with acute lymphoblastic leukemia (ALL) treated with 2 different CNS prophylaxis 40
Trattamento della leucemia linfoide acuta (LLA) in fase avanzata con l'associazione vincristina, ARA-C, methotrexate e prednisone 38
Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group. 38
Effetti a distanza della radiochemioterapia sul sistema nervoso centrale 38
THERAPY-RELATED ACUTE MYELOMONOCYTIC LEUKEMIA FOLLOWING SUCCESSFUL TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA 36
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 36
Etoposide, ARA-C a dosi intermedie e Carboplatino (VAC): un nuovo programma di chemioterapia attivo nella leucemia mieloide acuta (LMA) refrattaria e nella crisi blastica di leucemia mieloide cronica (LMC-CB) 34
Trattamento del linfoma linfoblastico: risultati di due diversi schemi di polichemioterapia intensiva 31
Seconda neoplasia in 5 pazienti affetti da leucemia linfoide acuta fuori terapia 31
Anemia sideropenica del bambino 30
Second tumors in long-term survivors of childhood acute lymphoblastic leukemia (ALL) 30
Childhood Myelodysplastic Syndrome (MDS): report of 4 cases 29
La chemioterapia nella leucemia mieloide acuta del bambino: stato attuale e prospettive future 28
Recidiva oculare e meningea off-therapy in un bambino affetto da LLA 27
I guariti da leucemia acuta: quanti e quale vita 27
Impiego delle IgG per via endovenosa ad alte dosi in preparazione ad interventi chirurgici nei bambini affetti da porpora trombocitopenica idiopatica 26
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 26
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 25
Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: Results of the randomized phase III EORTC-GIMEMA AML-19 Trial 25
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia 25
Therapy of acute nonlymphocytic leukemia in children. The AIEOP experience 24
Fattori prognostici cinetici nelle leucemie acute in trattamento con chemioterapia convenzionale e chemioterapia associata a citochine 24
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients 23
Second malignancies in long-term survivors of childhood acute lymphocytic leukemia 22
High dose ARA-C and Idarubicin for the treatment of advanced acute lymphocytic leukemia (ALL) 22
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT 22
Mitoxantrone, Etoposide and intermediate dose ARA-C (MEC) for the treatment of refractory acute myeloid leukemia 22
Mitoxantrone, etoposide and intermediate dose ARA-C (MEC) for the treatment of refractory acute myeloid leukemia 21
Terapia della leucemia acuta non linfoide del bambino 21
La chemioterapia della leucemia mieloide acuta del bambino: stato attuale e prospettive future 16
Therapy of childhood acute myelogenous leukemia (AML): the AIEOP LAM 87 and LAM 87M studies 16
Linfoadenopatie in età pediatrica: esperienza di tre anni in un Centro di Ematologia 16
Linfomi non Hodgkin in età pediatrica 16
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies 15
Idarubicn and high dose ARA-C in refractory ALL patients 14
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative 13
Therapy of acute nonlymphocytic leukemia in children. The AIEOP experience 12
Fatigue in long-term survivors of acute promyelocytic leukemia (APL) and its association with other symptoms and functional limitations 12
null 11
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial 5
IKZF1 (IKAROS) deletions represent a poor prognostic marker in BCR-ABL1 positive acute lymphoblastic leukaemia patients: a GIMEMA ALL WP report 4
Totale 2.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 0 62 69 60 49 33 39 8
2020/2021105 17 11 2 7 4 9 4 14 8 7 17 5
2021/2022505 9 20 29 47 88 16 8 34 41 47 66 100
2022/2023534 137 49 10 65 45 77 21 29 69 3 22 7
2023/2024207 30 32 7 23 18 17 4 1 0 35 18 22
2024/2025218 23 80 11 16 50 38 0 0 0 0 0 0
Totale 2.424